Healthcare -
Biotechnology - NASDAQ - US
$ 31.49
-0.317 %
$ 14 B
Market Cap
12.4
P/E
RPRX - TOTAL DEBT REPAID
Total Debt Repaid RPRX - Royalty Pharma plc
-1 B
LAST VALUE
-33.64%
2 YEAR CAGR
-27.74%
5 YEAR CAGR
0.00%
10 YEAR CAGR